37 results
DEFR14A
OCX
Oncocyte Corporation
22 May 23
Revised proxy
9:00am
percentiles in which executive compensation should fall so Oncocyte can be competitive in executive hiring and retention.
Report of the Audit Committee
8-K
EX-1.1
j8b7d
19 Apr 22
Oncocyte Corporation Announces Proposed Public Offering of Common Stock and Warrants
4:01pm
8-K
EX-1.1
wlcr1acbzp
14 Jun 21
Entry into a Material Definitive Agreement
12:00am
8-K
EX-1.1
7q6907g8
5 Feb 21
Oncocyte Announces Pricing of $35 Million Public Offering of Common Stock
5:15pm
PRER14A
x42xiuyz iy
18 May 20
Preliminary revised proxy
6:06am
8-K
EX-10.1
7u568wq0
20 Mar 20
Entry into a Material Definitive Agreement
4:30pm